Cidara Therapeutics, Inc.
6310 Nancy Ridge Dr Ste 101 San Diego
CA
92121-3209 United States
Superstring Capital Invests $6.84M in Axsome Therapeutics in Q4 2025
Analysis of Superstring Capital Management's new $6.84 million investment in Axsome Therapeutics in late 2025, highlighting the biopharma firm's commercial portfolio and CNS focus.
Source: IndexBox Mar 18, 2026
Superstring Capital Management Acquires $7.43M Stake in Sionna Therapeutics
Analysis of Superstring Capital Management's Q4 2025 investment in Sionna Therapeutics, a clinical-stage biotech company developing cystic fibrosis treatments, based on recent SEC filings and financial data.
Source: IndexBox Mar 18, 2026
Superstring Capital Acquires $5.69M Stake in Definium Therapeutics
Analysis of Superstring Capital Management's new $5.69 million investment in Definium Therapeutics, a clinical-stage biopharma company, as reported in a Q4 2025 SEC filing.
Source: IndexBox Mar 18, 2026
Superstring Capital Trims Terns Pharmaceuticals Stake in Q4 2025
Analysis of Superstring Capital Management's Q4 2025 reduction of its Terns Pharmaceuticals position, detailing the transaction size, portfolio impact, and company context.
Source: IndexBox Mar 18, 2026
Merck's Subdued 2026 Outlook: What it Means After Q4 Results?
MRK posts conservative 2026 sales and EPS outlook, given acquisition charges. Keytruda, Animal Health and new drug launches are expected to drive 2026 growth.
Source: Zacks Feb 6, 2026
Dow Jones Giant Merck Crushes Fourth-Quarter Views. But Guidance Rattles Shares.
Merck quashed fourth-quarter expectations Tuesday, but the Dow Jones health giant issued lackluster expectations for 2026.
Source: Investor's Business Daily Feb 3, 2026
- Adrenal Cortical Hormones
- Analgesics
- Antibiotics
- Antisera and Other Blood Fractions
- Autoclaves
- Blood-Grouping Reagents
- Diagnostic Reagents
- Immunological products, put up in measured doses
- Insulin
- Laboratory glassware
- Laboratory reagents
- Liquid chromatography instruments
- Medicaments containing alkaloids or derivatives
- Medicaments containing antibiotics
- Medicaments containing hormones
- Medicaments containing penicillins or derivatives
- Medicaments containing vitamins or provitamins
- Medicinal Capsules
- Microcentrifuges
- NMR spectrometers
- Ophthalmic Medicines
- Optical microscopes
- Precision balances
- Spectrometers
- Sterile surgical catgut, similar ster ile suture materials
- Thermal cyclers
- Vaccines for Human Medicine
- Wadding, gauze, bandages and similar articles
- Analgesics
- Antibiotics
- Antihistamines
- Antimalarial Drugs
- Antineoplastic and immunosuppressive medicaments
- Antivirals
- Biotechnology Reagents
- Cancer Drugs
- Chemical Analysis Equipment
- Chromatography Apparatus
- DNA Sequencing Equipment
- Electron Microscopes
- Erythromycin and its derivatives
- Insulin
- Insulin and its salts
- Laboratory Glassware
- Laboratory Reagents
- Medicaments containing hormones or steroids
- Microscopes
- Ophthalmic Solutions
- Paracetamol (acetaminophen)
- Penicillin and its derivatives
- Scientific Instruments
- Spectrophotometers
- Steroidal Hormones
- Streptomycins and their derivatives
- Tetracyclines and their derivatives
- Vaccines for Human Medicine
- Vitamins and their derivatives
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.
All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.